Zealand Pharma A/S - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Zealand Pharma R&D Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Friday, 5th of March of 2021.
I would like to hand the conference to our first speaker today. Emmanuel Dulac. Please go ahead, sir.
/-&
Thank you for joining this Q&A session of our R&D Day. I hope you found the presentations insightful and worthy of your time. I am honored to introduce this session. And before we jump to fit first in the session to answer your questions, we have 4 slides we would like to share.
If you turn to Slide 2. You will see the Q&A participants. I am joined by Adam Steensberg, our Head of R&D; Danilo Verge, Head of Medical Affairs; Matt Dallas, our CFO; and Rie Schultz Hansen, our Head of Discovery and Innovation.
On Slide 3, I want to remind everyone that during this presentation, we may make some forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

